0001493152-17-014716.txt : 20171218 0001493152-17-014716.hdr.sgml : 20171218 20171218151241 ACCESSION NUMBER: 0001493152-17-014716 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20171218 DATE AS OF CHANGE: 20171218 EFFECTIVENESS DATE: 20171218 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SignPath Pharma, Inc. CENTRAL INDEX KEY: 0001455694 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205079533 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-301014 FILM NUMBER: 171261218 BUSINESS ADDRESS: STREET 1: 3477 CORPORATE PARKWAY, SUITE 100 CITY: CENTER VALLEY STATE: PA ZIP: 18034 BUSINESS PHONE: 215-538-9996 MAIL ADDRESS: STREET 1: 3477 CORPORATE PARKWAY, SUITE 100 CITY: CENTER VALLEY STATE: PA ZIP: 18034 D 1 primary_doc.xml X0708 D LIVE 0001455694 SignPath Pharma, Inc. 9710 RUSKIN CIRCLE SANDY UT UTAH 84092 801-245-0313 DELAWARE None None Corporation true Kai Larson 9710 Ruskin Circle Sandy UT UTAH 84092 Executive Officer President and COO Arthur P. Bollon, Ph.D 9710 Ruskin Circle Sandy UT UTAH 84092 Director Jack Levine, CPA 9710 Ruskin Circle Sandy UT UTAH 84092 Director Robert Saguso 9710 Ruskin Circle Sandy UT UTAH 84092 Director Peter Sordillo 9710 Ruskin Circle Sandy UT UTAH 84092 Executive Officer Beth Hecht 9710 Ruskin Circle Sandy UT UTAH 84092 Director Pharmaceuticals Decline to Disclose 06b false 2017-11-30 false true true false 100000 Windsor Street Capital, L.P. 34171 John W. Stalanski 2922709 45 BROADWAY NEW YORK NY NEW YORK 10006 All States false 5000000 235000 4765000 true 0 4 450000 true 0 Windsor Street Capital L.P. will receive a 9% commission and a non-accountable expanse allowance equal to 2% of the gross proceeds on units purchased by members they introduced. 100000 true false SignPath Pharma, Inc. /s/ Kai Larson Kai Larson President & COO 2017-12-13